We are live on ! Find out more
FMTX

Forma Therapeutics Holdings, Inc. Common Stock
FMTX

Delisted

FMTX was delisted on the 13th of October, 2022.

Back to rankings

89 hedge funds and large institutions have $914M invested in Forma Therapeutics Holdings, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 29 increasing their positions, 27 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

78% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 9

33% more funds holding in top 10

Funds holding in top 10: 3 → 4 (+1)

9% more funds holding

Funds holding: 82 → 89 (+7)

7% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 27

9% less capital invested

Capital invested by funds: $1B → $914M (-$90M)

Holders
89
Holders Change
+7
Holders Change %
+8.54%
% of All Funds
1.56%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.07%
New
16
Increased
29
Reduced
27
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
LGM
Logos Global Management
California
+$21.3M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$11.8M
3
Renaissance Technologies
Renaissance Technologies
New York
+$1.94M
4
BlackRock
BlackRock
New York
+$1.79M
5
Morgan Stanley
Morgan Stanley
New York
+$1.75M

Top Sellers

1
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$19.3M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$17.8M
3
State Street
State Street
Massachusetts
-$16.9M
4
Wellington Management Group
Wellington Management Group
Massachusetts
-$5.3M
5
MWNA
Marshall Wace North America
New York
-$4.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
Macquarie Group
26
Macquarie Group
Australia
$2.16M – – –
EC
27
EcoR1 Capital
California
$2.09M -$366K -15,497 -15%
Renaissance Technologies
28
Renaissance Technologies
New York
$1.9M +$1.94M +81,900 New
Voloridge Investment Management
29
Voloridge Investment Management
Florida
$1.64M -$871K -36,836 -34%
AA
30
ALPS Advisors
Colorado
$1.42M -$29.6K -1,250 -2%
IHAM
31
Integral Health Asset Management
New York
$1.39M +$355K +15,000 +33%
Rafferty Asset Management
32
Rafferty Asset Management
New York
$1.28M -$946K -40,020 -42%
Dimensional Fund Advisors
33
Dimensional Fund Advisors
Texas
$1.23M +$1.25M +52,852 New
RhumbLine Advisers
34
RhumbLine Advisers
Massachusetts
$1.03M +$44.3K +1,875 +4%
State of Wisconsin Investment Board
35
State of Wisconsin Investment Board
Wisconsin
$965K – – –
Citigroup
36
Citigroup
New York
$903K -$2.57M -108,577 -74%
SFI
37
Susquehanna Fundamental Investments
Pennsylvania
$873K +$579K +24,492 +186%
Swiss National Bank
38
Swiss National Bank
Switzerland
$849K +$49.7K +2,100 +6%
Neuberger Berman Group
39
Neuberger Berman Group
New York
$749K +$764K +32,301 New
California State Teachers Retirement System (CalSTRS)
40
California State Teachers Retirement System (CalSTRS)
California
$738K -$295K -12,480 -28%
Susquehanna International Group
41
Susquehanna International Group
Pennsylvania
$708K -$131K -5,538 -15%
AllianceBernstein
42
AllianceBernstein
Tennessee
$696K -$54.4K -2,300 -7%
PL
43
Parkwood LLC
Ohio
$681K +$99.7K +4,217 +17%
HS
44
HighVista Strategies
Massachusetts
$619K -$46.7K -1,974 -7%
SG Americas Securities
45
SG Americas Securities
New York
$552K +$563K +23,822 New
JP Morgan Chase
46
JP Morgan Chase
New York
$536K +$93.3K +3,947 +21%
New York State Common Retirement Fund
47
New York State Common Retirement Fund
New York
$534K -$104K -4,398 -16%
ECM
48
ExodusPoint Capital Management
New York
$515K +$526K +22,227 New
UBS Group
49
UBS Group
Switzerland
$505K +$327K +13,825 +174%
CSS
50
Cubist Systematic Strategies
Connecticut
$479K +$273K +11,539 +127%
1
2
3 4

FMTX Hedge Fund Activity: Q3 2021 in Review

89 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Forma Therapeutics Holdings, Inc. Common Stock (FMTX) for Q3 2021, worth a combined $914M — down 9% from $1B a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new FMTX positions and 9 closed out — a net gain of 7 holders — while 29 added to existing stakes and 27 trimmed.

The largest buyer was Logos Global Management, adding an estimated $21.3M. The largest seller was Janus Henderson Group, exiting entirely with an estimated $19.3M sold.

  • 89 institutional investors held Forma Therapeutics Holdings, Inc. Common Stock (FMTX) as of Q3 2021, up from 82 in Q2 2021.
  • Funds reported $914M of Forma Therapeutics Holdings, Inc. Common Stock stock for Q3 2021, down 9% quarter-over-quarter.
  • 16 funds opened new Forma Therapeutics Holdings, Inc. Common Stock positions in Q3 2021 and 9 closed out, a net change of +7 holders.
  • The largest Forma Therapeutics Holdings, Inc. Common Stock buyer in Q3 2021 was Logos Global Management, an estimated $21.3M added.
  • The largest Forma Therapeutics Holdings, Inc. Common Stock seller in Q3 2021 was Janus Henderson Group, an estimated $19.3M sold.

Based on aggregated 13F filings for Q3 2021.